文献速递脑血管病外科神经重症

破裂脑动静脉畸形的延迟治疗:等待是否可行

Delayed treatment of ruptured brain AVMs: is it ok to wait?
PubMed 文献 · J Neurosurg · 2017-07-07

本研究纳入2000年1月至2015年12月在本机构接受至少出血后4周才治疗的破裂脑动静脉畸形患者,评估延迟治疗期间再出血或神经功能恶化的风险。102例中7例(6.9%)治疗失败,再出血率为每患者年11.5%或每患者月0.96%。作者认为出血后至少延迟4周干预再出血风险低(<1%),但发现相关动脉瘤等高危特征时会调整治疗策略。

要点

  • 破裂脑动静脉畸形出血后至少4周再治疗,再出血率为每患者月0.96%。
  • 102例中7例(6.9%)出现再出血或神经功能恶化。
  • 合并动脉瘤者再出血风险为每患者月11.4%。

核心结论

  • 出血后至少延迟4周干预再出血风险低(<1%)。
  • 发现相关颅内动脉瘤等高危特征时作者调整了治疗策略。

研究设计与样本

  • 回顾性分析2000年1月至2015年12月在本机构接受至少出血后4周治疗的破裂脑动静脉畸形患者。
  • 排除需急诊切除动静脉畸形、在外院已治疗或4周内因其他原因治疗的患者。
  • 主要结局为从初始出血至治疗失败(再出血或动静脉畸形直接导致的神经功能恶化)的时间。

主要发现

  • 102例破裂动静脉畸形中7例(6.9%)治疗失败。
  • 6例(5.8%)出现新发出血,中位时间248天(四分位距33-1364天)。
  • 总风险期为18,740患者日,再出血率为每患者年11.5%或每患者月0.96%。
  • 102例中12例(11.8%)合并动脉瘤,该组在动脉瘤处理前总风险期263患者日中发生1例(8.3%)新发出血,再出血风险为每患者月11.4%。

临床怎么用

  • 作者的做法是让脑动静脉畸形破裂后患者进行康复,并计划择期治疗动静脉畸形。
  • 作者认为这些数据量化了其治疗策略的风险。
  • 作者在发现相关颅内动脉瘤等高危特征时调整了治疗策略。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE Despite a hemorrhagic presentation, many patients with arteriovenous malformations (AVMs) do not require emergency resection. The timing of definitive management is not standardized in the cerebrovascular community. This study was designed to evaluate the safety of delaying AVM treatment in clinically stable patients with a new hemorrhagic presentation. The authors examined the rate of rehemorrhage or neurological decline in a cohort of patients with ruptured brain AVMs during a period of time posthemorrhage. METHODS Patients presenting to the authors' institution from January 2000 to December 2015 with ruptured brain AVMs treated at least 4 weeks posthemorrhage were included in this analysis. Exclusion criteria were ruptured AVMs that required emergency surgery involving resection of the AVM, prior treatment of AVM at another institution, or treatment of lesions within 4 weeks for other reasons (subacute surgery). The primary outcome measure was time from initial hemorrhage to treatment failure (defined as rehemorrhage or neurological decline as a direct result of the AVM). Patient-days were calculated from the day of initial rupture until the day AVM treatment was initiated or treatment failed. RESULTS Of 102 ruptured AVMs in 102 patients meeting inclusion criteria, 7 (6.9%) failed the treatment paradigm. Six patients (5.8%) had a new hemorrhage within a median of 248 days (interquartile range 33-1364 days). The total "at risk" period was 18,740 patient-days, yielding a rehemorrhage rate of 11.5% per patient-year, or 0.96% per patient-month. Twelve (11.8%) of 102 patients were found to have an associated aneurysm. In this group there was a single (8.3%) new hemorrhage during a total at-risk period of 263 patient-days until the aneurysm was secured, yielding a rehemorrhage risk of 11.4% per patient-month. CONCLUSIONS It is the authors' practice to rehabilitate patients after brain AVM rupture with a plan for elective treatment of the AVM. The present data are useful in that the findings quantify the risk of the authors' treatment strategy. These findings indicate that delaying intervention for at least 4 weeks after the initial hemorrhage subjects the patient to a low (< 1%) risk of rehemorrhage. The authors modified the treatment paradigm when a high-risk feature, such as an associated intracranial aneurysm, was identified.

来源:J Neurosurg,查看原文。版权归原作者所有。

引用

  1. Beecher JS, Lyon K, Ban VS, et al. Delayed treatment of ruptured brain AVMs: is it ok to wait? J Neurosurg. 2017. PMID: 28686111. doi:10.3171/2017.1.JNS16745

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。